Insight Holdings Group LLC Purchases Shares of 15,980 Axon Enterprise, Inc $AXON

Insight Holdings Group LLC acquired a new position in Axon Enterprise, Inc (NASDAQ:AXON) in the 1st quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor acquired 15,980 shares of the biotechnology company’s stock, valued at approximately $6,787,000. Axon Enterprise comprises 0.5% of Insight Holdings Group LLC’s investment portfolio, making the stock its 19th biggest holding.

Several other institutional investors have also bought and sold shares of the stock. Evergreen Capital Management LLC lifted its stake in Axon Enterprise by 3.8% during the 2nd quarter. Evergreen Capital Management LLC now owns 413 shares of the biotechnology company’s stock valued at $342,000 after acquiring an additional 15 shares in the last quarter. Synergy Financial Group LTD increased its position in shares of Axon Enterprise by 1.4% during the 3rd quarter. Synergy Financial Group LTD now owns 1,388 shares of the biotechnology company’s stock valued at $996,000 after purchasing an additional 19 shares during the last quarter. Tower Research Capital LLC TRC increased its position in shares of Axon Enterprise by 1.2% during the 2nd quarter. Tower Research Capital LLC TRC now owns 1,631 shares of the biotechnology company’s stock valued at $1,350,000 after purchasing an additional 19 shares during the last quarter. Certuity LLC boosted its holdings in shares of Axon Enterprise by 5.1% in the 4th quarter. Certuity LLC now owns 474 shares of the biotechnology company’s stock worth $269,000 after buying an additional 23 shares during the last quarter. Finally, Pure Financial Advisors LLC boosted its holdings in shares of Axon Enterprise by 6.7% in the 4th quarter. Pure Financial Advisors LLC now owns 364 shares of the biotechnology company’s stock worth $207,000 after buying an additional 23 shares during the last quarter. Institutional investors own 79.08% of the company’s stock.

Analyst Ratings Changes

Several analysts have commented on the stock. Citizens Jmp reaffirmed a “market outperform” rating and issued a $700.00 price objective on shares of Axon Enterprise in a research report on Thursday, June 25th. The Goldman Sachs Group set a $535.00 price target on shares of Axon Enterprise in a research note on Thursday, May 7th. Needham & Company LLC boosted their target price on Axon Enterprise from $600.00 to $750.00 and gave the company a “buy” rating in a research note on Monday, July 6th. Morgan Stanley set a $600.00 price objective on Axon Enterprise in a report on Thursday, May 7th. Finally, UBS Group lowered their price objective on Axon Enterprise from $570.00 to $440.00 and set a “neutral” rating on the stock in a research note on Thursday, May 7th. Fifteen analysts have rated the stock with a Buy rating and three have assigned a Hold rating to the company. Based on data from MarketBeat, Axon Enterprise has a consensus rating of “Moderate Buy” and an average target price of $725.25.

Axon Enterprise Stock Up 2.1%

AXON stock opened at $502.34 on Friday. The stock has a 50-day simple moving average of $483.26 and a two-hundred day simple moving average of $479.59. Axon Enterprise, Inc has a twelve month low of $339.01 and a twelve month high of $885.91. The firm has a market capitalization of $40.49 billion, a PE ratio of 201.74, a PEG ratio of 10.25 and a beta of 1.38. The company has a quick ratio of 1.93, a current ratio of 2.27 and a debt-to-equity ratio of 0.49.

Axon Enterprise (NASDAQ:AXON) last announced its quarterly earnings results on Wednesday, May 6th. The biotechnology company reported $1.61 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.60 by $0.01. Axon Enterprise had a net margin of 6.90% and a return on equity of 3.78%. The firm had revenue of $807.35 million for the quarter, compared to the consensus estimate of $778.90 million. During the same period in the prior year, the firm posted $1.47 earnings per share. The company’s revenue for the quarter was up 33.7% on a year-over-year basis. On average, equities analysts predict that Axon Enterprise, Inc will post 1.63 EPS for the current fiscal year.

Insider Buying and Selling at Axon Enterprise

In other Axon Enterprise news, Director Caitlin Elizabeth Kalinowski sold 564 shares of the stock in a transaction that occurred on Monday, June 1st. The shares were sold at an average price of $478.97, for a total value of $270,139.08. Following the sale, the director directly owned 3,632 shares in the company, valued at $1,739,619.04. This represents a 13.44% decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available through this hyperlink. Also, CRO Cameron Brooks sold 1,242 shares of the firm’s stock in a transaction on Thursday, June 4th. The shares were sold at an average price of $500.00, for a total transaction of $621,000.00. Following the completion of the transaction, the executive directly owned 49,710 shares of the company’s stock, valued at approximately $24,855,000. The trade was a 2.44% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders have sold a total of 58,989 shares of company stock worth $30,527,983 in the last ninety days. Insiders own 4.20% of the company’s stock.

Axon Enterprise Profile

Axon Enterprise, Inc develops technology and weapons systems for public safety and law enforcement agencies, combining hardware, software and cloud services. The company’s hardware portfolio includes conducted energy weapons (commonly known as TASER devices), body-worn cameras and in-car camera systems. Axon pairs these devices with a suite of connected products and accessories designed to capture, store and manage field evidence.

Beyond hardware, Axon operates a subscription-based software platform for digital evidence management, evidence review and records management.